23,500 results
Analysts at Maxim Group upped their price objective on shares of Sucampo Pharmaceuticals (NASDAQ:SCMP) from $15.00 to $19.00 in a research report issued to clients and investors on Tuesday. The firm currently has a “buy” rating on the stock.Intercooler · 1/21/2015
Sucampo Pharmaceuticals (NASDAQ:SCMP) had its target price boosted by WallachBeth Capital from $12.00 to $16.00 in a report issued on Tuesday. They currently have a buy rating on the stock. Shares of Sucampo Pharmaceuticals (NASDAQ:SCMP) …Mideast Times · 1/23/2015
Stock analysts at Maxim Group upped their price target on shares of Sucampo Pharmaceuticals (NASDAQ:SCMP) from $15.00 to $19.00 in a report issued on Tuesday. The firm currently has a “buy” rating on the stock. Maxim Group’s target price …sleekmoney.com · 1/21/2015
More from Bing News
Investors looking for well-ranked stocks in the pharma/biotech sector may consider Biodel Inc. (BIOD - Snapshot Report) and Sucampo Pharmaceuticals, Inc. (SCMP - Analyst Report). Both carry a Zacks Rank #1 (Strong Buy). Get the latest research …ZACKS · 4 hours ago
Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP), In a major positive the short interest in Sucampo Pharmaceuticals, Inc. – Class A Common Stock plummeted by 4.5% or 104,654 shares. The final shorts are 13.7% of the total floated shares. The …stafforddaily.com · 1/20/2015
SCMP, the publisher of Hong Kong’s only paid-for daily English-language newspaper, also faces a possible delisting because its publicly traded shares are set to fall below an exchange-imposed minimum. Kuok’s Kerry Media Ltd. is due to buy stock from ...Businessweek · 2/19/2013
Shanghai’s composite index of the biggest stocks in China just had its worst day since the ... (at a hefty interest rate), but they won’t be allowed to now. Here’s the SCMP: “There had been a guessing game on the level of tolerance by the regulator ...businessinsider.com.au · 1/19/2015
This week, these five stocks have the best ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader. For more information, get Portfolio Grader’s complete analysis of GLRI stock. Louis Navellier’s proprietary ...Investor Place · 8/8/2014
The announcement came almost four hours after its shares surged as much as 31 percent before the noon trading day lunch break with no immediate reason given for the jump. The shares closed up 23 percent at HK$2.15, prior to a trading suspension. The ...Reuters · ByStephen Aldred · 2/18/2013
Sucampo Pharmaceuticals, Inc. ( SCMP) was a big mover last session with its shares rising over 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the …NASDAQ · 10/13/2014
- © 2015 Microsoft |
- Privacy and Cookies |
- Legal |
- Advertise |
- About our ads |
- Help |
- Feedback